Moderna Coronavirus Vaccine Approved In EU

Moderna Coronavirus Vaccine Approved In EU
Moderna Coronavirus Vaccine Approved In EU

Video: Moderna Coronavirus Vaccine Approved In EU

Video: European Medicines Agency approves Moderna coronavirus vaccine 2022, December

The European Medicines Agency (EMA) has approved the use of an anti-toxic vaccine developed by Moderna. The decision must be approved by the EU authorities. Modern vaccine became the second after Pfizer / BioNTech approved for emergency use on the European continent.

The permission is conditional, according to the official EMA statement released today. This means that due to the pandemic, the vaccine will begin to be used before the end of the massive clinical trials (the last, third phase), which will continue for another two years. And all the while, the company is obliged to provide the results of ongoing testing. As noted by the head of the European Commission Ursula von der Leyen, work is now underway to approve this decision as soon as possible, after which the vaccine will become available for vaccination.

Like Pfizer / BioNTech, the Modern vaccine is intended for adult patients aged 18 and over. Both vaccines, according to the data provided by the developers, showed high efficiency at the level of 94-95%.

On Tuesday, January 5, at a WHO briefing, recommendations for the use of the Pfizer / BioNTech vaccine were announced - the drug was the first to be included in the list of vaccines recommended by the WHO for emergency use. In particular, cases of a severe reaction to vaccination were noted; in the results, WHO experts recommend that vaccinations be given in conditions where, in the event of post-vaccination anaphylactic shock, the patient can be provided with immediate assistance. Note that leaving patients under medical supervision for some time after vaccination and having the necessary drugs in the vaccination center to stop an allergic reaction is a standard requirement for vaccinations with almost any vaccine.

By the way, the WHO also noted that by the end of January they will give similar recommendations on the use of two more vaccines (without specifying the manufacturer), and in total, a special expert group is now working on the verification of a dozen vaccines developed in different countries.

At the end of December, the first case of an acute allergic reaction to the Moderna vaccine became known. This was reported by The New York Times. As it turned out, the patient was allergic, he received immediate assistance.

Popular by topic